{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T01:42:29Z","timestamp":1792978949201,"version":"4.5.0"},"reference-count":52,"publisher":"Ovid Technologies (Wolters Kluwer Health)","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background:<\/jats:title>\n                    <jats:p>Stevens\u2013Johnson syndrome (SJS) as a dermatological emergency, is a severe condition with a 5% mortality rate. Antiepileptic drugs (AEDs) are linked to an increased risk of SJS, but the magnitude of this risk varies between studies, so comprehensive investigations are needed to evaluate the prevalence of SJS complications associated with AEDs.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>\n                      Based on PRISMA guidelines, Online databases including PubMed\/Medline, CINAHL (EBSCO), Web of Science (ISI), Scopus, and Embase were searched using related MeSH-term. Studies reporting SJS as a complication of AEDs or considering AEDs suspected of inducing SJS were included. The Studies which not published in English mentioned other complications instead of skin manifestations were excluded. The data was analyzed using the STATA 14 software. To investigate heterogeneity, the Q Cochrane test and I\n                      <jats:sup>2<\/jats:sup>\n                      test were used, and the random effects model was used for combining articles.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>\n                      Of 1630 studies, 24 studies were included in meta-analysis. The overall pooled prevalence of SJS was 23.22% (95% CI: 17.32\u201329.11). The pooled prevalence of SJS was 22.56% (95% CI: 16.55\u201328.57) in the Retrospective Cohort; 30.90% (95% CI: 5.32\u201356.48) in perspective Cohort, 24.84% (95% CI: 18.02\u201331.67) in Asia, 11.20% (95% CI: 6.10\u201318.4) in America, and 11.70% (95% CI: 2.77\u201320.63) in Europe. The I\n                      <jats:sup>2<\/jats:sup>\n                      index for the overall pooled prevalence of SJS was 93.6%. The results of the meta-regression exhibited that the sample size, publication year, age, design study, and place showed no significant effect on heterogeneity (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      &gt; 0.05). This review found a significant prevalence of Stevens\u2013Johnson syndrome (SJS) linked to antiepileptic drugs (AEDs) at 23.22%.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions:<\/jats:title>\n                    <jats:p>Clinicians should be cautious when prescribing AEDs, especially to high-risk populations. More research is needed to understand SJS mechanisms and identify genetic markers for personalized treatment approaches.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.4103\/ijpvm.ijpvm_132_24","type":"journal-article","created":{"date-parts":[[2025,7,30]],"date-time":"2025-07-30T13:00:27Z","timestamp":1753880427000},"update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":4,"title":["The Prevalence of Stevens\u2013Johnson Syndrome Complications due to Antiepileptic Drug Use: A Systematic Review and Meta-Analysis"],"prefix":"10.4103","volume":"16","author":[{"given":"Samira","family":"Tardeh","sequence":"first","affiliation":[{"name":"Faculty of Medicine, Student Research Committee, Ilam University of Medical Sciences, Ilam, Iran"},{"name":"Department of Health Management, School of Health, Hamadan University of Medical Sciences, Hamadan, Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arezoo","family":"Sarmad","sequence":"additional","affiliation":[{"name":"Department of Health Information Management, School of Allied Medicine, Tehran University of Medical Sciences, Tehran, Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masoumeh","family":"Otaghi","sequence":"additional","affiliation":[{"name":"Department of Nursing, School of Nursing and Midwifery, Ilam University of Medical Sciences, Ilam, Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fatemeh","family":"Heydari","sequence":"additional","affiliation":[{"name":"Department of Epidemiology, Faculty of Health, Ilam University of Medical Sciences, Ilam, Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amir","family":"Adibi","sequence":"additional","affiliation":[{"name":"Department of Psychiatry Adolescent and Child, Medicine of Faculty, Ilam University of Medical Sciences, Ilam, Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zahra","family":"Malekan","sequence":"additional","affiliation":[{"name":"Department of Dentistry, School of Stomatology, Dalian Medical University, Dalian University, Dalian, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reza","family":"Pakzad","sequence":"additional","affiliation":[{"name":"Department of Epidemiology, Faculty of Health, Ilam University of Medical Sciences, Ilam, Iran"},{"name":"Faculty of Health, Student Research Committee, Ilam University of Medical Sciences, Ilam, Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2025,7]]},"reference":[{"key":"R1-20250825","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1586\/eci.11.66","article-title":"The current understanding of Stevens\u2013Johnson syndrome and toxic epidermal necrolysis","volume":"7","author":"Mockenhaupt","year":"2011","journal-title":"Expert Rev Clin Immunol"},{"key":"R2-20250825","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1001\/archderm.1993.01680220104023","article-title":"Clinical classification of cases of toxic epidermal necrolysis, Stevens-Johnson syndrome, and erythema multiforme","volume":"129","author":"Bastuji-Garin","year":"1993","journal-title":"Arch Dermatol"},{"key":"R3-20250825","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1016\/j.jaad.2011.09.029","article-title":"Toxic epidermal necrolysis:Review of pathogenesis and management","volume":"66","author":"Downey","year":"2012","journal-title":"J Am Acad Dermatol"},{"key":"R7-20250825","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1038\/sj.jid.5701033","article-title":"Stevens\u2013Johnson syndrome and toxic epidermal necrolysis:Assessment of medication risks with emphasis on recently marketed drugs. The EuroSCAR-study","volume":"128","author":"Mockenhaupt","year":"2008","journal-title":"J Invest Dermatol"},{"key":"R8-20250825","doi-asserted-by":"crossref","first-page":"1600","DOI":"10.1056\/NEJM199512143332404","article-title":"Medication use and the risk of Stevens\u2013Johnson syndrome or toxic epidermal necrolysis","volume":"333","author":"Roujeau","year":"1995","journal-title":"NEngl J Med"},{"key":"R9-20250825","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1001\/jamadermatol.2013.4114","article-title":"Relationship between the HLA-B*1502 allele and carbamazepine-induced Stevens-Johnson syndrome and toxic epidermal necrolysis:A systematic review and meta-analysis","volume":"149","author":"Tangamornsuksan","year":"2013","journal-title":"JAMA Dermatol"},{"key":"R10-20250825","doi-asserted-by":"crossref","first-page":"2178","DOI":"10.1111\/epi.13925","article-title":"The risk of Stevens-Johnson syndrome and toxic epidermal necrolysis in new users of antiepileptic drugs","volume":"58","author":"Frey","year":"2017","journal-title":"Epilepsia"},{"key":"R11-20250825","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1038\/clpt.2009.252","article-title":"ALDEN, an algorithm for assessment of drug causality in Stevens\u2013Johnson syndrome and toxic epidermal necrolysis:Comparison with case\u2013control analysis","volume":"88","author":"Sassolas","year":"2010","journal-title":"Clin Pharmacol Ther"},{"key":"R12-20250825","doi-asserted-by":"crossref","first-page":"k3155","DOI":"10.1136\/bmj.k3155","article-title":"Trends in outpatient antibiotic use and prescribing practice among US older adults, 2011-15:Observational study","volume":"362","author":"Olesen","year":"2018","journal-title":"BMJ"},{"key":"R13-20250825","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.1097\/CCM.0b013e31821201ed","article-title":"Toxic epidermal necrolysis and Stevens-Johnson syndrome:A review","volume":"39","author":"Gerull","year":"2011","journal-title":"Criti Care Med"},{"key":"R14-20250825","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1016\/j.anai.2018.05.022","article-title":"High-risk drug rashes","volume":"121","author":"Alvarado","year":"2018","journal-title":"Ann Allergy Asthma Immunol"},{"key":"R15-20250825","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.jaad.2007.08.036","article-title":"Allopurinol is the most common cause of Stevens-Johnson syndrome and toxic epidermal necrolysis in Europe and Israel","volume":"58","author":"Halevy","year":"2008","journal-title":"JAm Acad Dermatol"},{"key":"R16-20250825","doi-asserted-by":"crossref","DOI":"10.4065\/mcp.2009.0379","article-title":"Clinical, etiologic, and histopathologic features of Stevens-Johnson Syndrome during an 8-year period at Mayo Clinic","author":"Wetter","year":"2010","journal-title":"In Mayo Clinic Proceedings. Elsevier"},{"key":"R17-20250825","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1007\/s11882-018-0778-6","article-title":"Severe cutaneous adverse drug reactions:Presentation, risk factors, and management","volume":"18","author":"Mustafa","year":"2018","journal-title":"Curr Allergy Asthma Rep"},{"key":"R18-20250825","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1056\/NEJMoa1013297","article-title":"HLA-A*3101 and carbamazepine-induced hypersensitivity reactions in Europeans","volume":"364","author":"McCormack","year":"2011","journal-title":"N Eng J Med"},{"key":"R19-20250825","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1002\/cpt.81","article-title":"Patterns in spontaneous adverse event reporting among branded and generic antiepileptic drugs","volume":"97","author":"Bohn","year":"2015","journal-title":"Clin Pharmacol Ther"},{"key":"R20-20250825","first-page":"2732","article-title":"Spontaneous reporting of Stevens-Johnson syndrome and toxic epidermal necrolysis associated with antiepileptic drugs","volume":"19","author":"Ordo\u00f1ez","year":"2015","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"R21-20250825","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1007\/s40261-019-00754-z","article-title":"Adverse cutaneous drug reactions associated with old-and new-generation antiepileptic drugs using the Japanese pharmacovigilance database","volume":"39","author":"Hosohata","year":"2019","journal-title":"Clin Drug Investig"},{"key":"R22-20250825","article-title":"The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses","author":"Ga","year":"2000","journal-title":"In 3rd Symposium on Systematic Reviews:Beyond the Basics, Oxford, UK"},{"key":"R24-20250825","doi-asserted-by":"crossref","first-page":"1426","DOI":"10.1111\/j.1742-1241.2009.02168.x","article-title":"Health Outcomes Policy and Economics (HOPE) Collaborative Group. Understanding heterogeneity in meta-analysis:The role of meta-regression","volume":"63","author":"Baker","year":"2009","journal-title":"Int J Clin Pract"},{"key":"R25-20250825","doi-asserted-by":"crossref","first-page":"e17","DOI":"10.3346\/jkms.2020.35.e17","article-title":"Adverse skin reactions with antiepileptic drugs using Korea adverse event reporting system database, 2008\u20132017","volume":"35","author":"Kim","year":"2020","journal-title":"JKorean Med Sci"},{"key":"R26-20250825","doi-asserted-by":"crossref","first-page":"199","DOI":"10.4103\/0019-5154.96192","article-title":"Causative drugs and clinical outcome in Stevens Johnson syndrome (SJS) toxic epidermal necrolysis (TEN) and SJS-TEN overlap in children","volume":"57","author":"Sethuraman","year":"2012","journal-title":"Indian J Dermatol"},{"key":"R27-20250825","doi-asserted-by":"crossref","first-page":"203","DOI":"10.3904\/kjim.2012.27.2.203","article-title":"Causes and treatment outcomes of Stevens-Johnson syndrome and toxic epidermal necrolysis in 82 adult patients","volume":"27","author":"Kim","year":"2012","journal-title":"Korean J Int Med"},{"key":"R28-20250825","first-page":"8163588","article-title":"Clinical and epidemiological features of patients with drug-induced Stevens-Johnson syndrome and toxic epidermal necrolysis in Iran:Different points of children from adults","author":"Abtahi-Naeini","year":"2022","journal-title":"Int J Pediatr 2022"},{"key":"R29-20250825","doi-asserted-by":"crossref","first-page":"661891","DOI":"10.3389\/fmed.2021.661891","article-title":"Clinical aspects of Stevens-Johnson syndrome\/toxic epidermal necrolysis with severe ocular complications in Taiwan","volume":"8","author":"Ma","year":"2021","journal-title":"Front Med"},{"key":"R30-20250825","doi-asserted-by":"crossref","first-page":"e17","DOI":"10.5415\/apallergy.2022.12.e17","article-title":"Clinical characteristics of drug-induced Stevens-Johnson syndrome and toxic epidermal necrolysis:A single-center study","volume":"12","author":"Yoo","year":"2022","journal-title":"Asia Pac Allergy"},{"key":"R31-20250825","doi-asserted-by":"crossref","first-page":"23","DOI":"10.4103\/idoj.idoj_530_21","article-title":"The clinical characteristics, putative drugs, and optimal management of 62 patients with Stevens-Johnson Syndrome and\/or toxic epidermal necrolysis:A retrospective observational study","volume":"13","author":"Manvi","year":"2022","journal-title":"Indian Dermatol J"},{"key":"R32-20250825","first-page":"3061084","article-title":"Clinical features and treatment outcomes among children with Stevens-Johnson syndrome and toxic epidermal necrolysis:A 20-year study in a tertiary referral hospital","author":"Chatproedprai","year":"2018","journal-title":"Dermatol Res Pract 2018"},{"key":"R33-20250825","doi-asserted-by":"crossref","first-page":"25","DOI":"10.4103\/ijd.ijd_783_22","article-title":"Clinicoetiological Study of Stevens-Johnson Syndrome and Toxic Epidermal N ecrolysis Spectrum and the Correlation of Scorten with Prognosis","volume":"68","author":"Kanagarajan","year":"2023","journal-title":"Indian J Dermatol"},{"key":"R34-20250825","doi-asserted-by":"crossref","first-page":"123","DOI":"10.4168\/aair.2010.2.2.123","article-title":"Comparison of the causes and clinical features of drug rash with eosinophilia and systemic symptoms and Stevens-Johnson syndrome","volume":"2","author":"Jeung","year":"2010","journal-title":"Allergy Asthma Immunol Res"},{"key":"R35-20250825","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/j.jfda.2015.11.009","article-title":"Correlation between drugedrug interaction-induced StevenseJohnson syndrome and related deaths in Taiwan","volume":"24","author":"Cheng","year":"2016","journal-title":"J Food Drug Anal"},{"key":"R36-20250825","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.jdin.2021.03.008","article-title":"Delayed admission to a specialist referral center for Stevens-Johnson syndrome and toxic epidermal necrolysis is associated with increased mortality:A retrospective cohort study","volume":"4","author":"Clark","year":"2021","journal-title":"JAAD Int"},{"key":"R37-20250825","doi-asserted-by":"crossref","first-page":"195","DOI":"10.3904\/kjim.2015.365","article-title":"Direct costs of severe cutaneous adverse reactions in a tertiary hospital in Korea","volume":"34","author":"Yang","year":"2019","journal-title":"Korean J Intern Med"},{"key":"R38-20250825","first-page":"421","article-title":"An epidemiological study of Stevens-Johnson syndrome and toxic epidermal necrolysis during 2010-2015 at Shahid Faghihi Hospital, Shiraz, Iran","volume":"43","author":"Talebi","year":"2018","journal-title":"Iran J Med Sci"},{"key":"R39-20250825","first-page":"4320195","article-title":"The epidemiology of Stevens-Johnson syndrome and toxic epidermal necrolysis in China","author":"Yang","year":"2018","journal-title":"JImmunol Res 2018"},{"key":"R40-20250825","doi-asserted-by":"crossref","first-page":"1746","DOI":"10.1016\/j.vaccine.2019.12.028","article-title":"Erythema multiforme, Stevens Johnson syndrome, and toxic epidermal necrolysis reported after vaccination, 1999\u20132017","volume":"38","author":"Su","year":"2020","journal-title":"Vaccine"},{"key":"R41-20250825","doi-asserted-by":"crossref","first-page":"258","DOI":"10.4103\/idoj.IDOJ_437_20","article-title":"Factors predicting the outcome of Stevens\u2013Johnson syndrome and toxic epidermal necrolysis:A 5-year retrospective study","volume":"12","author":"Thakur","year":"2021","journal-title":"Indian Dermatol Online J"},{"key":"R42-20250825","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1111\/bcp.13445","article-title":"French Network of Regional Centres of Pharmacovigilance and the French Investigators for Adverse Skin Reactions to Drugs. Is acetaminophen associated with a risk of Stevens\u2013Johnson syndrome and toxic epidermal necrolysis?Analysis of the French Pharmacovigilance Database","volume":"84","author":"Lebrun-Vignes","year":"2018","journal-title":"Br J Clin Pharmacol"},{"key":"R43-20250825","doi-asserted-by":"crossref","first-page":"329","DOI":"10.2147\/PPA.S285256","article-title":"Quality of life of drug reaction with eosinophilia and systemic symptom (DRESS) and Stevens-Johnson syndrome (SJS) and\/or toxic epidermal necrolysis (TEN) patients","volume":"15","author":"Perwitasari","year":"2021","journal-title":"Patient Prefer Adherence"},{"key":"R44-20250825","doi-asserted-by":"crossref","first-page":"80","DOI":"10.4103\/0253-7613.106441","article-title":"Retrospective analysis of Steven Johnson syndrome and toxic epidermal necrolysis over a period of 5 years from northern Karnataka, India","volume":"45","author":"Naveen","year":"2013","journal-title":"Indian J Pharmacol"},{"key":"R45-20250825","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.4103\/0366-6999.204929","article-title":"Retrospective analysis of Stevens-Johnson syndrome and toxic epidermal necrolysis in 88 Chinese patients","volume":"130","author":"Wang","year":"2017","journal-title":"Chinese Med J"},{"key":"R46-20250825","doi-asserted-by":"crossref","first-page":"25","DOI":"10.4103\/0019-5154.77546","article-title":"Retrospective analysis of Stevens-Johnson syndrome and toxic epidermal necrolysis over a period of 10 years","volume":"56","author":"Sanmarkan","year":"2011","journal-title":"Indian J Dermatol"},{"key":"R47-20250825","doi-asserted-by":"crossref","first-page":"12","DOI":"10.4103\/ijd.IJD_671_21","article-title":"Stevens\u2013Johnson syndrome and toxic epidermal necrolysis:11-year demographic clinical and prognostic characteristics","volume":"67","author":"Acar","year":"2022","journal-title":"Indian J Dermatol"},{"key":"R48-20250825","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1097\/01.all.0000173785.81024.33","article-title":"Epidemiology of hypersensitivity drug reactions","volume":"5","author":"Gomes","year":"2005","journal-title":"Curr Opin Allergy Clin Immunol"},{"key":"R49-20250825","doi-asserted-by":"crossref","first-page":"2318","DOI":"10.1111\/epi.14591","article-title":"Stevens-Johnson syndrome and toxic epidermal necrolysis with antiepileptic drugs:An analysis of the US food and drug administration adverse event reporting system","volume":"59","author":"Borrelli","year":"2018","journal-title":"Epilepsia"},{"key":"R50-20250825","doi-asserted-by":"crossref","first-page":"329","DOI":"10.3177\/jnsv.44.329","article-title":"Decline in plasma retinol in unconjugated hyperbilirubinemia treated with bilirubin adsorption using an anion-exchange resin","volume":"44","author":"Ihara","year":"1998","journal-title":"J Nutr Sci Vitaminol"},{"key":"R51-20250825","doi-asserted-by":"crossref","first-page":"133","DOI":"10.12659\/MSM.891043","article-title":"Stevens-Johnson syndrome and toxic epidermal necrolysis (SJS\/TEN):Could retinoids play a causative role?","volume":"21","author":"Mawson","year":"2015","journal-title":"Med Sci Monit"},{"key":"R52-20250825","doi-asserted-by":"crossref","first-page":"135","DOI":"10.2147\/JIR.S160964","article-title":"A meta-analysis of cyclosporine treatment for Stevens\u2013Johnson syndrome\/toxic epidermal necrolysis","volume":"11","author":"Ng","year":"2018","journal-title":"J Inflamm Res"},{"key":"R53-20250825","first-page":"142","article-title":"Severe drug-induced skin reactions:Clinical pattern, diagnostics and therapy","volume":"7","author":"Mockenhaupt","year":"2009","journal-title":"J Dtsch Dermatol Ges"},{"key":"R54-20250825","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1056\/NEJMoa1009717","article-title":"Carbamazepine-induced toxic effects and HLA-B*1502 screening in Taiwan","volume":"364","author":"Chen","year":"2011","journal-title":"N Engl J Med"},{"key":"R55-20250825","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1097\/FPC.0b013e328330a3b8","article-title":"Strong association between HLA-B*5801 and allopurinol-induced Stevens\u2013Johnson syndrome and toxic epidermal necrolysis in a Thai population","volume":"19","author":"Tassaneeyakul","year":"2009","journal-title":"Pharmacogenet Genomics"},{"key":"R56-20250825","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/s13601-017-0188-1","article-title":"Stevens\u2013Johnson syndrome\/toxic epidermal necrolysis and erythema multiforme drug-related hospitalisations in a national administrative database","volume":"8","author":"Sousa-Pinto","year":"2018","journal-title":"Clin Transl Allergy"}],"container-title":["International Journal of Preventive Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.4103\/ijpvm.ijpvm_132_24","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T16:52:20Z","timestamp":1787763140000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/ijpvm.ijpvm_132_24"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7]]},"references-count":52,"URL":"https:\/\/doi.org\/10.4103\/ijpvm.ijpvm_132_24","relation":{},"ISSN":["2008-7802","2008-8213"],"issn-type":[{"value":"2008-7802","type":"print"},{"value":"2008-8213","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7]]},"assertion":[{"value":"2024-05-07","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-09-11","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}